VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MBOT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MBOTMicrobot Medical Inc.
$1.93$88M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMBOTQuarterly Financials

Microbot Medical Inc. (MBOT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Microbot Medical Inc. (MBOT) quarterly income statement — complete revenue, gross profit & net income history

MBOT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue105K0000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold103K0012K026K0028K35K0000000000
COGS % of Revenue98.1%-------------------
Gross Profit2K00-12K0-26K00-28K-35K0000000000
Gross Margin %1.9%-------------------
Gross Profit Growth %-100%--100%25.71%--------------
Operating Expenses4.32M4.14M3.86M3.71M3.02M3.4M3.3M2.51M2.36M2.03M2.54M2.32M2.92M3.07M3.47M3.56M3.18M3.94M2.55M2.48M
OpEx % of Revenue4116.19%-------------------
Selling, General & Admin3.03M2.38M2.69M1.61M1.56M1.45M1.24M1.09M1.22M938K932K959K1.3M1.41M1.52M1.37M1.47M1.89M1.16M1.09M
SG&A % of Revenue2884.76%-------------------
Research & Development1.29M1.54M1.17M2.1M1.46M1.96M2.06M1.42M1.14M1.09M1.61M1.36M1.62M1.88M1.95M2.19M1.71M2.26M1.39M1.39M
R&D % of Revenue1231.43%-------------------
Other Operating Expenses0213K00000000000-224K000-206K00
Operating Income-4.32M-4.14M-3.86M-3.72M-3.02M-3.43M-3.3M-2.51M-2.38M-2.07M-2.54M-2.32M-2.92M-3.07M-3.47M-3.56M-3.18M-3.94M-2.55M-2.48M
Operating Margin %-4114.29%-------------------
Operating Income Growth %-43%-20.64%-17%-48.27%-26.72%-65.86%-29.72%-8.05%18.33%32.59%26.77%34.77%8.09%22.07%-36.13%-43.9%-32.78%-49.87%-5.67%-31.42%
EBITDA-4.31M-4.13M-3.85M-3.71M-3.01M-3.4M-3.28M-2.5M-2.36M-2.03M-2.52M-2.3M-2.89M-3.04M-3.45M-3.54M-3.15M-3.91M-2.54M-2.46M
EBITDA Margin %-4102.86%-------------------
EBITDA Growth %-43.31%-21.27%-17.52%-48.62%-27.59%-67.44%-29.83%-8.66%18.59%33.01%26.82%35.08%8.27%22.36%-36%-43.79%-32.9%-49.66%-5.84%-31.87%
D&A (Non-Cash Add-back)12K10K10K12K15K26K23K14K28K35K20K26K25K33K25K23K21K28K16K14K
EBIT-4.32M-4.14M-3.86M-3.5M-3.02M-3.39M-3.3M-2.51M-2.38M-3.15M-2.54M-2.32M-2.92M-3.07M-3.47M-3.56M-3.18M-3.94M-2.55M-2.48M
Net Interest Income649K00223K104K38K85K46K13K66K98K37K66K75K6K50K-13K78K-3K-35K
Interest Income649K00223K104K38K85K46K13K66K98K37K66K75K6K50K078K00
Interest Expense000000000000000013K03K35K
Other Income/Expense649K674K284K223K420K38K85K46K13K-1.09M98K37K66K70K6K50K-13K78K-3K-35K
Pretax Income-3.67M-3.46M-3.58M-3.5M-2.6M-3.39M-3.21M-2.46M-2.37M-3.15M-2.45M-2.29M-2.85M-3M-3.47M-3.51M-3.19M-3.86M-2.56M-2.51M
Pretax Margin %-3496.19%-------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.67M-3.46M-3.58M-3.5M-2.6M-3.39M-3.21M-2.46M-2.37M-3.15M-2.45M-2.29M-2.85M-3M-3.47M-3.51M-3.19M-3.86M-2.56M-2.51M
Net Margin %-3496.19%-------------------
Net Income Growth %-41.14%-2.12%-11.26%-41.99%-9.7%-7.55%-31.44%-7.78%16.89%-5.2%29.47%34.9%10.54%22.31%-35.73%-39.9%-33.54%-46.34%-3.36%-35.36%
Net Income (Continuing)-3.67M-3.46M-3.58M-3.5M-2.6M-3.39M-3.21M-2.46M-2.37M-3.15M-2.45M-2.29M-2.85M-3M-3.47M-3.51M-3.19M-3.86M-2.56M-2.51M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.05-0.05-0.07-0.100.01-0.20-0.20-0.17-0.17-0.26-0.21-0.25-0.36-0.39-0.49-0.49-0.45-0.54-0.36-0.35
EPS Growth %-74.2%62.8%43.59%103.59%23.08%4.76%32%52.78%33.33%57.14%48.98%20%27.78%-36.11%-40%-32.35%-45.95%-2.86%-34.62%
EPS (Basic)-0.05-0.05-0.07-0.100.01-0.20-0.20-0.17-0.17-0.26-0.21-0.25-0.36-0.39-0.49-0.49-0.45-0.54-0.36-0.35
Diluted Shares Outstanding67.16M67.16M48.1M36.49M17.02M17.02M16.47M14.85M14.06M12.13M11.71M9.2M8.01M7.72M7.11M7.11M7.11M7.11M7.11M7.11M
Basic Shares Outstanding67.16M67.16M48.1M36.49M17.02M17.02M16.47M14.85M14.06M12.13M11.71M9.2M7.92M7.72M7.11M7.11M7.11M7.11M7.11M7.11M
Dividend Payout Ratio--------------------